Begin typing your search above and press return to search.

Bharat Biotech to Ramp up Covaxin Production by 200 Million

Bharat Biotech on Thursday announced the quick ramp up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million.

Covaxin

Sentinel Digital Desk

HYDERABAD: Bharat Biotech on Thursday announced the quick ramp up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million. The manufacturing capacities for India's first indigenous Covid vaccine have been ramped up at Chiron Behring Vaccines, a wholly-owned subsidiary of Bharat Biotech at Ankleshwar, Gujarat. (IANS)

Also Read :Disheartening to hear states complaining: Bharat Biotech


Next Story